Medicine & Life Sciences
Positron-Emission Tomography
100%
methyl iodide
71%
Brain
62%
Serotonin Plasma Membrane Transport Proteins
57%
Ligands
46%
Radioactivity
44%
Angiotensin Type 1 Receptor
36%
Cannabinoid Receptors
34%
2-butyl-5-methoxymethyl-6-(1-oxopyridin-2-yl)-3-((2'-(1H-tetrazol-5-yl)bipohenyl-4-yl)methyl)-3H-imidazo(4,5-b)pyridine
34%
Electrons
32%
Papio
31%
Nicotinic Receptors
30%
Kidney
29%
naltrindole
27%
Carbon-11
27%
L 159884
27%
High Pressure Liquid Chromatography
26%
N-((2'-(((4,5-dimethyl-3-isoxazolyl)amino)sulfonyl)-4-(2-oxazolyl)(1,1'-biphenyl)-2-yl)methyl)-N,4-fluorobenzamide
23%
Alkylation
22%
3-(2-(pyrrolidinyl)methoxy)pyridine
22%
N-Methyl-3,4-methylenedioxyamphetamine
22%
pyridine
21%
Opioid Receptors
20%
J 104132
20%
Serotonin
20%
A 69024
20%
Endothelin A Receptors
18%
Corpus Striatum
18%
Molecular Imaging
18%
delta Opioid Receptor
17%
A 85380
17%
N,N-diethyl-2-(2-(4-methoxyphenyl)-5,7-dimethyl-pyrazolo(1,5-a)pyrimidin-3-yl)-acetamide
16%
Dopamine Plasma Membrane Transport Proteins
16%
Halogens
15%
Angiotensin II
15%
Amines
14%
Microglia
14%
Heart
14%
benzoyl chloride
13%
Designer Drugs
13%
Autoradiography
13%
Fluorine-18
13%
Metabotropic Glutamate 5 Receptor
13%
Endothelin Receptors
13%
Kinetics
13%
Angiotensin Receptors
12%
Cerebellum
11%
2-iodoadenosine
11%
kappa Opioid Receptor
11%
Dopamine D1 Receptors
11%
Chemical Compounds
Radioligand
49%
Radiochemical Yield
44%
Positron
43%
Radioactivity
36%
Naltrindole
23%
Acetylcholine
19%
Purification
18%
Antagonist
17%
Iodomethane
16%
Ligand
14%
Iodide
14%
Time
14%
Epibatidine
10%
Purity
10%
Narcotic Antagonist
10%
Pyridine
9%
Displacement
9%
Protecting Group
9%
2-Fluoroadenosine
8%
Cannabinoid Receptor Antagonist
8%
Benzoyl Chloride
8%
Halogen
8%
Endothelin Receptor Antagonist
7%
Agent Interacting With Transmitter, Hormone or Drug Receptor
7%
Hydrogenolysis
7%
Designer Drug
6%
Angiotensin II
6%
Haloperidol
6%
Benzylation
6%
Cannabinoid
5%
Anaesthetic
5%
Fluoride
5%
Paclitaxel
5%
Ammonium Hydroxide
5%
Pharmacokinetics
5%
Beta-Amyloid
5%